A detailed history of Opinicus Capital, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Opinicus Capital, Inc. holds 3,707 shares of LLY stock, worth $2.88 Million. This represents 2.63% of its overall portfolio holdings.

Number of Shares
3,707
Previous 3,646 1.67%
Holding current value
$2.88 Million
Previous $3.3 Billion 0.51%
% of portfolio
2.63%
Previous 2.78%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $47,100 - $58,561
61 Added 1.67%
3,707 $3.28 Billion
Q2 2024

Jul 22, 2024

BUY
$724.87 - $909.04 $15,222 - $19,089
21 Added 0.58%
3,646 $3.3 Billion
Q1 2024

Apr 16, 2024

BUY
$592.2 - $792.28 $23,688 - $31,691
40 Added 1.12%
3,625 $2.82 Billion
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $1.88 Million - $2.22 Million
3,585 New
3,585 $2.09 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Opinicus Capital, Inc. Portfolio

Follow Opinicus Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opinicus Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opinicus Capital, Inc. with notifications on news.